We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kathryn Gessner

Kathryn Hacker Gessner MD, PhD

Society of Urologic Oncology Fellow, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Dr. Kathryn Hacker Gessner is a Society of Urologic Oncology fellow at the University of North Carolina at Chapel Hill. She completed her medical training in the UNC MD-PhD program, during which she obtained a PhD in Genetics and Molecular Biology. Following graduation, she completed urology residency at the University of North Carolina at Chapel Hill. Dr. Gessner’s research interests include the genomic characterization of genitourinary malignancies, elucidating the molecular alterations driving tumor development and growth, and implementing targeted therapy based on individual tumor characteristics.

Disclosures

Dr. Gessner has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Clinical Features of Cyclophosphamide-Associated Bladder Cancer